Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Alzheimers Dement. 2017 Mar 3;13(9):985–992. doi: 10.1016/j.jalz.2017.01.023

Table 2.

Association of Floor Maze test performance (immediate maze time and delayed maze time) with incidence of mild cognitive impairment syndrome (MCI), motoric cognitive risk syndrome (MCR) and major cognitive impairment (either MCI or MCR). Hazard ratios are reported for each 10-second increase in IMT, DMT and Maze time difference.

Incident cases, n Adjusted Hazard Ratio (95% CI), p-value*
Immediate Maze Time
MCI 41 1.254 (1.063–1.480), p = 0.007
 Amnestic MCI 19 0.991 (0.769–1.277), p = 0.944
 Non-amnestic MCI 22 1.198 (1.067–1.345), p = 0.002
MCR 30 1.530 (1.230–1.903), p < 0.001
Major Cognitive Impairment 55 1.264 (1.069–1.494), p = 0.006
Delayed Maze time
MCI 41 1.187 (0.897–1.571), p = 0.230
 Amnestic MCI 19 0.847 (0.460–1.559), p = 0.593
 Non-amnestic MCI 22 1.137 (0.867–1.492), p = 0.354
MCR 30 1.321 (1.031–1.693), p = 0.028
Major Cognitive Impairment 55 1.493 (1.119–1.993), p = 0.006
Maze time difference (DMT-IMT)**
MCI 41 0.760 (0.615–0.939), p = 0.011
Amnestic MCI 19 0.987 (0.705–1.381), p = 0.937
Non-amnestic MCI 22 0.805 (0.688–0.942), p = 0.007
MCR 30 0.763 (0.593–0.981), p = 0.035
Major Cognitive Impairment 55 0.864 (0.691–1.080), p = 0.199
*

Adjusted for age, sex, education, Blessed test score, Global Health Scale score, and maze errors

**

Maze time difference is the difference between DMT and IMT in each participant, and is a measure of learning.